FIBRINOLYSIS IN MYOCARDIAL INFARCTION

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Fibrinolysis in myocardial infarction.

Fibrinolysis is the process of fibrin digestion by an enzyme system present in the blood. Although fibrinolytic activity has been found in the normal, and in many pathological states, its role remains obscure. It seems likely, however, that such a process may take part in the normal hamostatic equilibrium of the body and may be operative in the processes of resolution and healing (Astrup, 1956)...

متن کامل

Fibrinolysis for Acute Myocardial Infarction

Pharmacological reperfusion therapy for acute myocardial infarction was incorporated into the armamentarium of clinicians over 15 years ago and has had an extraordinarily beneficial impact on outcome of patients with ST-elevation myocardial infarction (STEMI). There are 3 fundamental components to pharmacological reperfusion; these consist of the core fibrinolytic agent as well as the accompany...

متن کامل

Fibrinolysis or angioplasty in acute myocardial infarction?

Early reperfusion during myocardial infarction limits myocardial injury and reduces mortality. Fibrinolysis (with streptokinase, or tissue or recombinant plasminogen activators) is today an established method for the treatment of myocardial infarction patients manifesting ST-segment elevation or left bundle branch block at ECG (electrocardiography), effective reperfusion being obtained in fifty...

متن کامل

Tenecteplase: Innovative Fibrinolysis for ST-Segment Elevation Myocardial Infarction (STEMI)

The use of fibrinolytic agents in the early treatment of ST-segment elevation myocardial infarction (STEMI) is known to significantly reduce mortality. Accelerated (“frontloaded”) alteplase is being challenged as the standard of care for pharmacological reperfusion. Alteplase, reteplase, and streptokinase have several limitations. The search for newer agents has focused on developing a fibrinol...

متن کامل

Behçet's syndrome presenting as myocardial infarction with impaired blood fibrinolysis.

A 34 year old man with no known coronary risk factors presented with acute myocardial infarction. Shortly after admission, and over the next eight years, he had recurring clinical features consistent with a diagnosis of Behçet's syndrome. Coronary angiograms recorded six months after infarction were normal. Although he was well with maintenance steroid treatment, blood fibrinolysis was impaired...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Heart

سال: 1958

ISSN: 1355-6037

DOI: 10.1136/hrt.20.1.15